News

DIAGNOS Secures $4 Million Funding for Innovative Solutions

DIAGNOS Secures $4 Million Funding for Innovative Solutions

DIAGNOS Closes Oversubscribed Private Placement Successfully

BROSSARD, Quebec — Diagnos Inc. (“DIAGNOS” or the “Company”) (TSXV: ADK and OTCQB: DGNOF) is excited to share the results of its successful closing of an upsized private placement offering. This initiative raised significant funds, with a total of 13,337,262 units sold at an issue price of $0.30 per unit, yielding aggregate proceeds of $4,001,178.60.

Leadership and Legal Guidance

The Offering was orchestrated by Centurion One Capital Corp., who acted as the lead agent in this transaction, ensuring the process was seamless and efficient. Legal representation included Borden Ladner Gervais LLP for the Company and MLT Aikins LLP for the Lead Agent, guiding them through crucial regulatory frameworks.

Insights from the Company President

André Larente, the President of DIAGNOS, expressed enthusiasm regarding the completion of this oversubscribed funding round. He noted, "DIAGNOS is pleased to announce this accomplishment, reflecting strong investor interest. The expertise brought by Centurion One Capital, combined with strategic investors, has positioned us to capitalize effectively on current market demand. This funding is vital for advancing our regulatory initiatives with Health Canada and the FDA, enhancing product development, and broadening commercial deployments. We are committed to delivering long-term value to our stakeholders."

Utilization of Funds

The net proceeds from this Offering will strategically support various key areas, including regulatory affairs, product development, and overall business growth. With these funds, DIAGNOS aims to strengthen its position within the healthcare sector, focusing on innovative solutions for eye health.

Details on Unit Composition

Each unit comprises one common share and one purchase warrant. The securities issued are subject to a statutory hold period of four months and one day, concluding on April 6, 2026. Each warrant enables its holder to purchase an additional share at $0.40 for eighteen months post-closing.

Regulatory Compliance and Related Transactions

In compliance with the regulations, the Company disclosed that certain related parties, comprising two directors and one officer, participated in this Offering, collectively acquiring 316,665 units. This transaction, categorized as a “related party transaction,” adheres to the exemptions specified in Multilateral Instrument 61-101, safeguarding minority shareholders' interests.

Investment Notifications

The Company paid a cash commission amounting to $153,974.40, in addition to issuing 666,863 units as a corporate finance fee, accompanied by 513,248 broker warrants. Each broker warrant can be exercised to obtain a unit at the issue price until June 6, 2027.

About DIAGNOS Inc.

DIAGNOS is dedicated to the early detection of critical eye-related health issues. By leveraging cutting-edge Artificial Intelligence technology, DIAGNOS enhances diagnostic accuracy, optimizes workflows, and improves patient outcomes globally. The commitment to innovation is at the heart of their mission.

About Centurion One Capital Corp.

Centurion One Capital cultivates visionary entrepreneurship amongst its clientele, driving transformative growth through capital investment and expertise. Their approach fosters partnerships based on shared values of respect, integrity, and a commitment to excellence in execution.

Frequently Asked Questions

What is the purpose of the $4 million raised by DIAGNOS?

The funds will support regulatory initiatives, accelerate product development, and expand commercial deployments in the eye health sector.

Who led the private placement for DIAGNOS?

Centurion One Capital Corp. served as the lead agent and sole bookrunner for this oversubscribed private placement.

What are the benefits of the units issued in the Offering?

Each unit consists of one common share and one warrant, offering investors opportunities for further participation in the Company's growth.

How does DIAGNOS utilize Artificial Intelligence?

DIAGNOS employs AI technology to improve diagnostic accuracy and streamline workflows in treating eye-related health issues.

What is the impact of the related party transaction?

Related parties participated in the Offering, which helps align the interests of management with those of shareholders, ensuring a commitment to the Company’s future success.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 137

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 666

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 332

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 513

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 410

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 348

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Global Child Tests Purpose Travel's Expanding Media Reach

Updated Category News Views 45

Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...

Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 98

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 191

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading

Top 5 Most Recently Viewed Articles

DEWALT Invests $4 Million in Future Trades Professionals

Updated Category News Views 104

DEWALT Invests Substantially in Skills Development In a notable effort to strengthen the future of skilled trades, DEWALT has revealed plans to allocate nearly $4 million in Grow the Trades grants to 166 organizations dedicated to training, retraining, and enhancing the skills of tradespeople across the U.S. and Canada. This initiative forms part of a broader commitment...

Continue Reading
Fairfax Financial Reports Spectacular Q3 Earnings Boost

Updated Category News Views 152

Fairfax Financial Holdings Limited Financial Results Overview Fairfax Financial Holdings Limited (TSX: FFH) recently shared its financial results for the third quarter, showcasing a robust increase in net earnings and strong operational performance. The results for this period underscore the company's commitment to growth, stability, and strategic acquisitions, focusing...

Continue Reading
U.S. Postal Service Board Meeting: Open to Public Attendance

Updated Category News Views 195

U.S. Postal Service Board of Governors Meeting Overview The U.S. Postal Service Board of Governors is set to convene for an important session that invites public observation. This meeting, hosted at the headquarters, is an opportunity for community engagement and transparency into the board's activities. Meeting Details and Agenda The open session is scheduled to begin in...

Continue Reading
Franklin Financial Revamps Portfolio and Keeps Dividend Steady

Updated Category News Views 198

Franklin Financial Restructures Its Investment Portfolio Franklin Financial Services Corp (NASDAQ:FRAF), the parent company of Farmers and Merchants Trust Company, has recently executed a notable reshuffling of its investment portfolio. The firm initiated the sale of approximately $46.7 million in lower-yielding U.S. Treasury securities, leading to an estimated after-tax...

Continue Reading
Discovering the Remarkable Growth of Sterling Infrastructure

Updated Category News Views 163

Understanding Sterling Infrastructure's Growth Over Time Sterling Infrastructure (NASDAQ: STRL) has consistently outperformed the market over the past decade. With an impressive annualized growth rate of 42.7%, this company has provided its investors with remarkable returns, boasting an average annual return of 55.14%. Presently, Sterling Infrastructure enjoys a robust...

Continue Reading